Ameriprise Financial Inc. Acquires 1,319 Shares of Koninklijke Philips (NYSE:PHG)

Ameriprise Financial Inc. grew its position in Koninklijke Philips (NYSE:PHG) by 3.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 45,842 shares of the technology company’s stock after buying an additional 1,319 shares during the quarter. Ameriprise Financial Inc.’s holdings in Koninklijke Philips were worth $1,164,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Farther Finance Advisors LLC lifted its holdings in shares of Koninklijke Philips by 37.1% in the 4th quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company’s stock worth $54,000 after buying an additional 582 shares during the period. Whipplewood Advisors LLC purchased a new stake in shares of Koninklijke Philips in the 4th quarter worth $55,000. Millstone Evans Group LLC purchased a new stake in shares of Koninklijke Philips in the 4th quarter worth $60,000. Allworth Financial LP lifted its holdings in shares of Koninklijke Philips by 24.9% in the 4th quarter. Allworth Financial LP now owns 3,993 shares of the technology company’s stock worth $105,000 after buying an additional 797 shares during the period. Finally, Smartleaf Asset Management LLC lifted its holdings in shares of Koninklijke Philips by 177.4% in the 4th quarter. Smartleaf Asset Management LLC now owns 4,489 shares of the technology company’s stock worth $114,000 after buying an additional 2,871 shares during the period. 13.67% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. BNP Paribas upgraded Koninklijke Philips from a “neutral” rating to an “outperform” rating in a report on Tuesday, February 25th. Wall Street Zen cut Koninklijke Philips from a “buy” rating to a “hold” rating in a research note on Friday. Sanford C. Bernstein upgraded Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, March 18th. Finally, UBS Group upgraded Koninklijke Philips from a “neutral” rating to a “buy” rating in a research note on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy”.

Koninklijke Philips Stock Up 0.3%

Shares of PHG stock opened at $23.04 on Monday. The stock’s 50-day simple moving average is $23.97 and its 200-day simple moving average is $25.50. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.74 and a current ratio of 1.23. The firm has a market capitalization of $21.66 billion, a PE ratio of -27.43, a P/E/G ratio of 0.82 and a beta of 0.81. Koninklijke Philips has a fifty-two week low of $21.48 and a fifty-two week high of $32.91.

Koninklijke Philips (NYSE:PHG) last announced its quarterly earnings data on Tuesday, May 6th. The technology company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.13. The business had revenue of $4.31 billion for the quarter, compared to analyst estimates of $4.10 billion. Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. The company’s revenue was down 1.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.21 earnings per share. Equities analysts expect that Koninklijke Philips will post 1.63 earnings per share for the current year.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.